TrialTargeted oncology2023

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data.

Mahmoud Mohammadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.